Sulphur Springs Union School District, CA Assigned 'A+' Issuer Credit Rating Feb 13

  • ID: 2419547
  • February 2013
  • Standard & Poors
1 of 3

SAN FRANCISCO (Standard & Poor's) Feb. 20, 2013--Standard & Poor's Ratings Services assigned its 'A+' issuer credit rating (ICR) to Sulphur Springs Union School District, Calif. The outlook is stable. "The 'A+' ICR reflects our view of the district's very strong income levels, diverse tax base, and low debt burden," said Standard & Poor's credit analyst Alda Mostofi. The stable outlook reflects our view that the district will maintain at least an adequate financial position during our two-year outlook horizon despite drawdowns. RELATED CRITERIA AND RESEARCH USPF Criteria: GO Debt, Oct. 12, 2006 USPF Criteria: Appropriation-Backed Obligations, June 13, 2007 USPF Criteria: Bond Anticipation Note Rating Methodology, Aug. 31, 2011...

Companies mentioned in this report are:
- Sulphur Springs Un Sch Dist

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Sulphur Springs Un Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.